Accordingly, in this review, we will summarize the latest findings concerned with the metabolic contribution of obesity in OA pathogenesis, with particular emphasis on dyslipidemia, insulin resistance and adipokines. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.